These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


731 related items for PubMed ID: 16076372

  • 1. Fibroblast growth factor 23 and its receptors.
    Yu X, White KE.
    Ther Apher Dial; 2005 Aug; 9(4):308-12. PubMed ID: 16076372
    [Abstract] [Full Text] [Related]

  • 2. FGF23 and disorders of phosphate homeostasis.
    Yu X, White KE.
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):221-32. PubMed ID: 15863037
    [Abstract] [Full Text] [Related]

  • 3. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
    Quarles LD.
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
    [Abstract] [Full Text] [Related]

  • 4. Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23.
    Imel EA, Econs MJ.
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():434-9. PubMed ID: 17982392
    [Abstract] [Full Text] [Related]

  • 5. FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets.
    Imel EA, Hui SL, Econs MJ.
    J Bone Miner Res; 2007 Apr; 22(4):520-6. PubMed ID: 17227222
    [Abstract] [Full Text] [Related]

  • 6. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
    Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, Minagawa M, Sugimoto T, Yamauchi M, Michigami T, Matsumoto T.
    Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126
    [Abstract] [Full Text] [Related]

  • 7. Serum FGF23 levels in normal and disordered phosphorus homeostasis.
    Weber TJ, Liu S, Indridason OS, Quarles LD.
    J Bone Miner Res; 2003 Jul; 18(7):1227-34. PubMed ID: 12854832
    [Abstract] [Full Text] [Related]

  • 8. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J, Liu S, Quarles LD.
    Semin Dial; 2007 Jul; 20(4):302-8. PubMed ID: 17635819
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia.
    Aono Y, Yamazaki Y, Yasutake J, Kawata T, Hasegawa H, Urakawa I, Fujita T, Wada M, Yamashita T, Fukumoto S, Shimada T.
    J Bone Miner Res; 2009 Nov; 24(11):1879-88. PubMed ID: 19419316
    [Abstract] [Full Text] [Related]

  • 10. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.
    Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T.
    Proc Natl Acad Sci U S A; 2001 May 22; 98(11):6500-5. PubMed ID: 11344269
    [Abstract] [Full Text] [Related]

  • 11. Emerging role of a phosphatonin in mineral homeostasis and its derangements.
    Bielesz B.
    Eur J Clin Invest; 2006 Aug 22; 36 Suppl 2():34-42. PubMed ID: 16884396
    [Abstract] [Full Text] [Related]

  • 12. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
    Liu S, Gupta A, Quarles LD.
    Curr Opin Nephrol Hypertens; 2007 Jul 22; 16(4):329-35. PubMed ID: 17565275
    [Abstract] [Full Text] [Related]

  • 13. Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia.
    Shimizu Y, Tada Y, Yamauchi M, Okamoto T, Suzuki H, Ito N, Fukumoto S, Sugimoto T, Fujita T.
    Bone; 2009 Oct 22; 45(4):814-6. PubMed ID: 19555782
    [Abstract] [Full Text] [Related]

  • 14. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.
    ADHR Consortium.
    Nat Genet; 2000 Nov 22; 26(3):345-8. PubMed ID: 11062477
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of phosphate homeostasis in infants, children, and adolescents, and the role of phosphatonins in this process.
    Garabedian M.
    Curr Opin Pediatr; 2007 Aug 22; 19(4):488-91. PubMed ID: 17630616
    [Abstract] [Full Text] [Related]

  • 17. Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis.
    Goldsweig BK, Carpenter TO.
    Curr Osteoporos Rep; 2015 Apr 22; 13(2):88-97. PubMed ID: 25620749
    [Abstract] [Full Text] [Related]

  • 18. The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome.
    Yamamoto T, Imanishi Y, Kinoshita E, Nakagomi Y, Shimizu N, Miyauchi A, Satomura K, Koshiyama H, Inaba M, Nishizawa Y, Jüppner H, Ozono K.
    J Bone Miner Metab; 2005 Apr 22; 23(3):231-7. PubMed ID: 15838626
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.
    Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T.
    J Bone Miner Res; 2004 Mar 22; 19(3):429-35. PubMed ID: 15040831
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.